Antibodies to neuronal structures: Innocent bystanders or neurotoxins?

Diabetes Care

Volumn 28, Issue 8, 2005, Pages 2067-2072

  Vinik, Aaron I ^a   Anandacoomaraswamy, Dharshan ^a   Ullal, Jagdeesh ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; FAS LIGAND; GANGLIOSIDE ANTIBODY; GANGLIOSIDE GM1; GLUTAMATE DECARBOXYLASE; IMMUNOGLOBULIN G ANTIBODY; MYELIN ASSOCIATED GLYCOPROTEIN; NICOTINIC RECEPTOR; PROTEIN ANTIBODY; RECEPTOR ANTIBODY;

AUTOIMMUNITY; AUTONOMIC NEUROPATHY; DIABETES MELLITUS; DIABETIC NEUROPATHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PERIPHERAL NEUROPATHY; REVIEW;

AUTOANTIBODIES; AUTONOMIC NERVOUS SYSTEM DISEASES; DIABETIC NEUROPATHIES; HUMANS; ISLETS OF LANGERHANS; NEURONS;

EID: 23044512600     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.8.2067     Document Type: Review

References (62)

1. Vinik EJ, Hayes RP, Oglesby A, Bastyr E, Barlow P, Ford-Molvik SL, Vinik AI: The development and validation of the Norfolk QOL-DN, a new measure of patients' perception of the effects of diabetes and diabetic neuropathy. Diabetes Technol Ther 7:497-508, 2005
2. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D, the American Diabetes Association: Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28:956-962, 2005
3. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Fach JM, Wilson DM, O'Brien PC, Melton LJ 3rd, Service FJ: The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43:817-824, 1993
4. Watkins PJ: Progression of diabetic autonomic neuropathy. Diabet Med 10 (Suppl, 2):77S-78S, 1993
5. Levitt NS, Stansberry KB, Wychanck S, Vinik AI: Natural progression of autonomic neuropathy and autonomic function tests in a cohort of IDDM. Diabetes Care 19:751-754, 1996
6. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 19:257-267, 1996
7. Hunt JV, Dean RT, Wolff SP: Hydroxyl radical production and autoxidative glycosylation: glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing. Biochem J 256:205-212, 1988
8. Vinik A, Erbas T, Stansberry KB, Pittenger G: Small fiber neuropathy and neurovascular disturbances in diabetes mellitus. Exp Clin Endocrinol Diabetes 109 (Suppl. 2):S451-S473, 2001
9. Vinik A, Pittenger G, Stansberry K, Park TS, Erbas T: Neurotrophic factors. In Textbook of Diabetic Neuropathy. Stuttgart, Germany, Georg Thiem Verlag, 2003, p. 129-169
10. Waksman BH, Adams RD: Allergic neuritis: an experimental disease of rabbits induced by the injection of peripheral nervous tissue and adjuvants. J Exp Med 102:213-236, 1955
11. Donev SR: Ultrastructural evidence for the presence of a glial sheath investing the islets of Langerhans in the pancreas of mammals. Cell Tissue Res 237:343-348, 1984
12. Winer S, Tsui H, Lau A, Song A, Li X, Cheung RK, Sampson A, Afifiyan F, Elford A, Jackowski G, Becker DJ, Santamaria P, Ohashi P, Dosch HM: Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive. Nat Med 9:198-205, 2003
13. Hoeldtke RD, Bryner KD, Horvath GG, Byerly MR, Hobbs GR, Marcovina SM, Lernmark A: Antibodies to GAD and glycemic control in recent-onset IDDM. Diabetes Care 20:1900-1903, 1997
14. Hoeldtke RD, Bryner KD, Hobbs GR, Horvath GG, Riggs JE, Christie I, Ganser G, Marcovina SM, Lernmark A: Antibodies to glutamic acid decarboxylase and peripheral nerve function in type 1 diabetes. J Clin Endocrinol Metab 85:3297-3308, 2000
15. Jaeger C, Allendorfer J, Hatziagelaki E, Dyrberg T, Bergis KH, Federlin K, Bretzel RG: Persistent GAD 65 antibodies in long-standing IDDM are not associated with residual beta-cell function, neuropathy or HLA-DRstatus. Horm Metab Res 29:510-515, 1997
16. Zanone MM, Burchio S, Quadri R, Pietropaolo M, Sacchetti C, Rabbone I, Chiandussi L, Cerutti F, Peakman M: Autonomic function and autoantibodies to autonomic nervous structures, glutamic acid decarboxylase and islet tyrosine phosphatase in adolescent patients with IDDM. J Neuroimmunol 87:1-10, 1998
17. Pittenger GL, Liu D, Vinik AI: The neuronal toxic factor in serum of type 1 diabetic patients is a complement-fixing autoantibody. Diabet Med 12:380-386, 1995
18. Pittenger GL, Liu D, Vinik AI: The apoptotic death of neuroblastoma cells caused by serum from patients with insulin-dependent diabetes and neuropathy may be Fas-mediated. J Neuroimmunol 76: 153-160, 1997
19. Sharma K, Cross J, Farronay O, Ayyar D, Sheber R, Bradley W: Demyelinating neuropathy in diabetes mellitus. Arch Neurol 59:758-765, 2002
20. Chin RL, Latov N: Peripheral neuropathy and celiac disease. Curr Treat Options Neurol 7:43-48, 2005
21. Sharma K, Cross J, Ayyar D, Martinez-Arizala A, Bradley W: Diabetic demyelinating polyneuropathy responsive to intravenous immunoglobulin therapy. Arch Neurol 59:751-757, 2002
22. Milicevic Z, Newlon PG, Pittenger GL, Stansberry KB, Vinik AI: Anti-ganglioside GM1 antibody and distal symmetric "diabetic polyneuropathy" with dominant motor features. Diabetologia 40:1364-1365, 1997
23. Vinik AI, Pittenger GL, Stansberry KB, Powers A: Phospholipid and glutamic acid decarboxylase autoantibodies in diabetic neuropathy. Diabetes Care 18:1225-1232, 1995
24. Pittenger GL, Burcus N, Malik R, Vinik AI: Cytotoxicity of serum on sensory/autonomic and motor neural cells in vitro predicts sensory neuropathy. (Abstract). Diabetes 46 (Suppl. 1):125A, 1997
25. Guy RJC, Richards F, Edmonds ME, Watkins PJ: Diabetic autonomic neuropathy and iritis: an association suggesting an immunological cause. Br Med J (Clin Res Ed) 289:343-345, 1984
26. Cachia MJ, Peakman M, Zanone M, Watkins PJ, Vergani D: Reproducibility and persistence of neural and adrenal autoantibodies in diabetic autonomic neuropathy. Diabet Med 14:461-465, 1997
27. Stroud CR, Heller SR, Ward JD, Hardisty CA, Weetman AP: Analysis of antibodies against components of the autonomic nervous system in diabetes mellitus. QJM 90:577-585, 1997
28. De Riva C: Hypoglycaemia unawareness in a young boy with insulin-dependent diabetes mellitus and anti-adrenal medullary antibodies. Diabetes Metab 23:528-532, 1997
29. Brown FM, Brink SJ, Freeman R, Rabinowe SL: Anti-sympathetic nervous system autoantibodies: diminished catecholamines with orthostasis. Diabetes 38:938-941, 1989
30. Shigeta H, Yamaguchi M, Nakano K, Obayashi H, Takemura R, Fukui M, Fujii M, Yoshimori K, Hasegawa G, Nakamura N, Kitagawa Y, Kondo M: Serum autoantibodies against sulfatide and phospholipid in NIDDM patients with diabetic neuropathy. Diabetes Care 20:1896-1899, 1997
31. Sundkvist G, Lind P, Bergstrom B, Lilja B, Rabinowe SL: Autonomic nerve antibodies and autonomic nerve function in type 1 and type 2 diabetic patients. J Intern Med 229:505-510, 1991
32. Husebye ES, Winqvist O, Sundkvist G, Kampe O, Karlsson FA: Autoantibodies against adrenal medulla in type 1 and type 2 diabetes mellitus: no evidence for an association with autonomic neuropathy. J Intern Med 239:139-146, 1996
33. Ejskjaer N, Arif S, Dodds W, Zanone MM, Vergani D, Watkins PJ, Peakman M: Prevalence of autoantibodies to autonomic nervous tissue structures in type 1 diabetes mellitus. Diabet Med 16:544-549, 1999
34. Vernino S, Adamski J, Kryzer TJ, Fealey RD, Lennon VA: Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology 50:1806-1813, 1998
35. Sandroni P, Vernino S, Klein CM, Lennon VA, Benrud-Larson L, Sletten D, Low PA: Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody. Arch Neurol 61:44-48, 2004
36. Klein CM, Vernino S, Lennon VA, Sandroni P, Fealey RD, Benrud-Larson L, Sletten D, Low PA: The spectrum of autoimmune autonomic neuropathies. Ann Neurol 53:752-758, 2003
37. Lennon VA, Ermilov LG, Szurszewski JH, Vernino S: Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J Clin Invest 111:907-913, 2003
38. Goldstein DS, Holmes C, Dendi R, Li ST, Brentzel S, Vernino S: Pandysautonomia associated with impaired ganglionic neurotransmission and circulating antibody to the neuronal nicotinic receptor. Clin Auton Res 12:281-285, 2002
39. Perego L, Previtali SC, Nemni R, Longhi R, Carandente O, Saibene A, Sciolla R, Villa A, Gai P, Panzeri C, Dell'Antonio G, Quattrini A, Folli F: Autoantibodies to amphiphysin I and amphiphysin II in a patient with sensory-motor neuropathy. Eur Neurol 47:196-200, 2002
40. Stacher G, Merio R, Budka C, Schneider C, Smolen J, Tappeiner G: Cardiovascular autonomic function, autoantibodies, and esophageal motor activity in patients with systemic sclerosis and mixed connective tissue disease. J Rheumatol 27:692-697, 2000
41. Jackson MW, Gordon TP, Waterman SA: Disruption of intestinal motility by a calcium channel-stimulating autoantibody in type 1 diabetes. Gastroenterology 126: 819-828, 2004
42. Zanone MM, Banga JP, Peakmen M, Edmonds M, Watkins PJ: An investigation of antibodies to nerve growth factor in diabetic autonomic neuropathy. Diabet Med 11:378-383, 1994
43. Granberg V, Ejskjaer N, Peakman M, Sundkvist G: Autoantibodies to autonomic nerves associated with cardiac and peripheral autonomic neuropathy. Diabetes Care 28:XXXX-XXXX, 2005
44. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA: Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 343:847-855, 2000
45. Vernino S, Cheshire WP, Lennon VA: Myasthema gravis with autoimmune autonomic neuropathy. Auton Neurosci 88: 187-192, 2001
46. Bogousslavsky J, Regli F, Doret AM, Fulpius BW, Ostinelli B, Rabinowicz T, Ruzicka J: Encephalopathy, peripheral neuropathy, dysautonomia, myasthenia gravis, malignant thymoma, and antiacetylcholine receptor antibodies in the CSF. Eur Neurol 22:301-306, 1983
47. O'Suilleabhain P, Low PA, Lennon VA: Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome: serologic and clinical correlates. Neurology 50:88-93, 1998
48. Lennon VA, Kryzer TJ, Griesmann GE, O'Suilleabhain PE, Windebank AJ, Woppmann A, Miljanich GP, Lambert EH: Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 332: 1467-1474, 1995
49. Kaiser R: [Paraneoplastic neurologic syndromes: diagnostic and pathogenetic significance of autoantibodies] (Review). Nervenarzt 70:688-701, 1999 [article in German]
50. Antoine JC, Camdessanche JP: [Paraneoplastic peripheral neuropathies] (Review). Rev Neurol (Paris) 160:188-198, 2004 [article in French]
51. Camdessanche JP, Antoine JC, Honnorat J, Vial C, Petiot P, Convers P, Michel D: Paraneoplastic peripheral neuropathy associated with anti-Hu antibodies: a clinical and electrophysiological study of 20 patients. Brain 125:166-175, 2002
52. Winkler AS, Dean A, Hu M, Gregson N, Chaudhuri KR: Phenotypic and neuropathologic heterogeneity of anti-Hu antibody-related paraneoplastic syndrome presenting with progressive dysautonomia: report of two cases. Clin AutonRes 11: 115-118, 2001
53. Lucchinetti CF, Kimmel DW, Lennon VA: Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies. Neurology 50: 652-657, 1998
54. Kusunoki S, Kanazawa I: [Carcinomatous autonomic neuropathy and the autoantibodies in paraneoplastic neuropathy] (Review). Nippon Rinsho 50:834-839, 1992 [article in Japanese]
55. Dalmau J, Clouston PD: Paraneoplastic syndromes (Letter). Neurology 42:1429, 1992
56. Anderson NE, Rosenblum MK, Graus F, Wiley RG, Posner JB: Autoantibodies in paraneoplastic syndromes associated with small-cell lung cancer. Neurology 38: 1391-1398, 1988
57. Vernino S, Lennon VA: New Purkinje cell antibody (PCA-2): marker of lung cancer-related neurological autoimmunity. Ann Neurol 47:297-305, 2000
58. Uncini A, Santoro M, Corbo M, Lugaresi A, Latov N: Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies. Muscle Nerve 16:610-615, 1993
59. Vernino S, Lennon VA: Autoantibody profiles and neurological correlations of thymoma. Clin Cancer Res 10:7270-7275, 2004
60. Zanone MM, Peakman M, Purewal T, Watkins PJ, Vergani D: Autoantibodies to nervous tissue structures are associated with autonomic neuropathy in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 36:564-569, 1993
61. Antoine JC, Camdessanche JP, Ferraud K, Caudie C: Antiganglioside antibodies in paraneoplastic peripheral neuropathies. J Neurol Neurosurg Psychiatry 75:1765-1767, 2004
62. Kusunoki S, Chiba A, Tai T, Kanawawa I: Localization of GM1 and GD1b antigens in the human peripheral nervous system. Muscle Nerve 16:752-756, 1993